The present study was designed to elucidate the relationship between p53 and ceramide, both of which are involved in apoptotic signaling. Treatment of human glioma cells with etoposide caused apoptosis only in cells expressing functional p53. p53 activation was followed by the formation of reactive oxygen species (ROS), superoxide anion (O 2 ) measured by hydroethidium oxidation into ethidium and hydrogen peroxide (H 2 O 2 ) measured by oxidation of 2',7'-dichloro¯uorescin (DCFH) into 2',7'-dichloro¯uorescein (DCF), which was accompanied with ceramide generation through the activation of neutral, but not acid, sphingomyelinase. Superoxide dismutase (SOD), a selective antioxidant for O 2 7.
, had no eects on p53 expression but inhibited ceramide generation and apoptotic cell death caused by etoposide. However, catalase, a speci®c antioxidant for H 2 O 2 , only weakly inhibited and sodium formate, a hydroxyl radical (
. OH) scavenger, unaected etoposide-induced apoptosis. Like etoposide-induced cell death, treatment of glioma cells with the O 2 7.
-releasing agent, pyrogallol, induced typical apoptosis and ceramide generation even in the presence of catalase. In contrast, human glioma cells lacking functional p53, either due to mutation or the expression of E6 protein of human papillomavirus, were highly resistant to etoposide and exhibited no signi®cant change in the ceramide level. Moreover, expression of functional p53 protein in glioma cells expressing mutant p53 using a temperature-sensitive human p53
Val138 induced ceramide accumulation by the activation of neutral sphingomyelinase which was dependent on the generation of O 2 7.
. Taken together, these results suggest that p53 may modulate ceramide generation by activation of neutral sphingomyelinase through the formation of O 2 7.
Introduction
Elevation of intracellular ceramide levels occurs in response to ligation of death receptors (Cifone et al., 1994; Tepper et al., 1997; Schwandner et al., 1998) . Ceramide accumulation has also been observed in response to various extracellular stimuli including girradiation, ultraviolet light, and the chemotherapeutic agents which upregulate p53, and cause apoptosis and/ or cell cycle arrest (Haimovitz-Friedman et al., 1994; JareÂ zou et al., 1996; Dbaibo et al., 1998; Tepper et al., 1999) . The addition of exogenous ceramide, such as cell-permeable C 2 -ceramide, has been associated with several anti-proliferative responses including cell dierentiation, apoptosis, and cell cycle arrest (Okazaki et al., 1990; Jayadev et al., 1995) . Therefore, ceramide has been proposed as a mediator of apoptosis and as a coordinator of the cellular responses to stresses (Hannun, 1996) . In C6 glioma cells, C 2 -ceramide induces apoptosis (Yoshimura et al., 1997) . Recently, we have observed that etoposide, a DNA topoisomerase II inhibitor, causes ceramide accumulation through sphingomyelin (SM) hydrolysis by the action of neutral and magnesium-dependent sphingomyelinase (N-SMase) during apoptotic death of C6 glioma cells and that decrease in the etoposide-induced ceramide formation by agents which inhibit N-SMase activity results in blockage of apoptosis (Sawada et al., 2000b) . These results suggest that ceramide functions as a mediator of apoptotic death of glioma cells. However, the mechanism of ceramide formation, in other words, the activation of N-SMase by a DNA-damaging agent, etoposide is poorly understood.
DNA damage can lead to the activation of p53 (Levine, 1997) . p53 is a tumor suppressor gene which is frequently mutated and/or deleted in numerous types of cancer (Hollstein et al., 1991) including brain tumors (Frankel et al., 1992) . Functional p53 protein is prerequisite either to arrest cell cycle through the G 1 / S interphase for the repair of damaged DNA (Lin et al., 1992) or alternately to promote apoptosis, when DNA damage is too extreme (Lowe et al., 1993) . The growth arrest is shown to be dependent on the transcriptional induction of the protein p21 WAF1/CIP1 (Levine, 1997) , but the mechanisms underlying the progression of p53-dependent apoptosis are largely unknown. This could be due to the uncertainty of the downstream mediator(s) of p53 during apoptosis. However, some recent reports suggest a role for reactive oxygen species (ROS) as a potential mediator of p53-dependent apoptosis (Johnson et al., 1996; Polyak et al., 1997; Li et al., 1999) . Apoptosis can be induced by ROS, such as hydrogen peroxide (Lennon et al., 1991; Huang et al., 2000) , oxygen radicals (Ramakrishnan and Catravas, 1992) , and nitric oxide (Brune et al., 1997) . In contrast, induction of apoptosis is inhibited by antioxidants and by superoxide dismutase or catalase (Busciglio and Yankner, 1995; Moreno-Manzano et al., 2000; Huang et al., 2000) . The recent observations that reduced glutathione (GSH) and N-acetylcysteine (NAC), which are known as antioxidants, inhibit the activation of N-SMase by apoptotic inducers (Liu et al., 1998; Yoshimura et al., 1999; Sawada et al., 2000b) suggest the possible involvement of ROS in ceramide accumulation. p53-dependent ceramide formation was demonstrated in Molt-4 and L292 cells (Dbaibo et al., 1998) .
In the present study, we have examined the functional relationship between p53 and ceramide, and also tested the intermediary roles of ROS between them. For these purposes, the level of functional p53 was modulated by the expression of type 16 human papillomavirus (HPV-16) E6 oncoprotein. Furthermore, functional p53 was overexpressed using temperature-sensitive human p53 in glioma cells expressing mutant p53. The data obtained indicate that functional p53 is prerequisite for production of ROS, ceramide accumulation, and apoptotic death of gliomas in response to etoposide. -releasing agent, pyrogallol. These results suggest that p53 modulates intracellular ceramide levels through generation of O 2 7. in apoptotic glioma cells.
Results

Etoposide induces p53-dependent apoptosis and ceramide formation
Inactivation of p53 can be accomplished by the expression of E6 protein of HPV-16, which binds p53 and accelerates its proteolytic degradation through the ubiquitin pathway (Schener et al., 1993) . Using a retroviral vector, wild-type or mutant E6 proteins and empty vector were expressed in U-87 MG cells (designated as U87-W E6, U87-M E6, and U87-LXSN, respectively). The mutant E6 (16E6SD-8S9A10T) has substitutions of amino acids, Arg, Pro and Arg at positions 8, 9, and 10 with the corresponding amino acids, Ser, Ala and Thr, respectively, from the`low risk' type 11 HPV E6, and is inactive for degrading p53 but active for other known E6 functions such as activation of telomerase (Klingelhutz et al., 1996) . Etoposide (VP-16), a DNA topoisomerase II inhibitor, which induces DNA damage and p53 expression (Walker et al., 1991) , ultimately causes apoptotic cell death (Sawada et al., 2000b) . Since p53 expression was almost completely suppressed in U87-W E6 cells exposed to less than 40 mg/ml etoposide (data not shown), we used 40 mg/ml etoposide in further experiments. Etoposide caused time-dependent accumulation of p53 protein in U87-LXSN and U87-M E6 cells (Figure 1a ). During the time course examined, Figure 1a ). In addition, etoposide failed to induce p53 upregulation in U-373 MG ( Figure  1a) and T-98 G cells (data not shown), both of which expressed mutant p53 (Gomez-Manzano et al., 1996) .
We have previously shown that etoposide induced ceramide accumulation in C6 rat glioma cells (Sawada et al., 2000b) . Thus, in the current study, we compared the apoptotic rates and ceramide contents at 12 h after treatment of 40 mg/ml etoposide among the cell lines expressing dierent p53 status. In U87-LXSN and U87-M E6 cells, which exhibited increased p53 expression, signi®cant ceramide formation was observed in response to etoposide and cells became apoptotic ( 
p53-dependent neutral SMase activation during etoposide treatment
Since neutral and acid SMases are known to be involved in ceramide accumulation in response to apoptotic inducers (Hannun, 1996; Jarezou et al., 1996) , changes of their activities were measured. In U87-LXSN and U87-M E6 cells, but not in U87-W E6 and U-373 MG cells, etoposide gave rise to a sharp increase in N-SMase activity at 12 h (threefold increase over the control level) (Figure 1b ). On the other hand, in all cell lines tested, signi®cant changes were not observed in acid SMase (A-SMase) activity (data not shown), as observed in C6 glioma cells treated with etoposide (Sawada et al., 2000b) .
Formation of reactive oxygen species during etoposide-induced apoptosis
As previously reported (Sawada et al., 2000b) , etoposide-induced activation of N-SMase was accompanied with reduction of cellular GSH and was inhibited by antioxidants, NAC and pyrrolidinedithiocarbamate (PDTC). Therefore, it is very likely that ROS regulates ceramide formation by N-SMase activation. ROS, including O 2
, H 2 O 2 , and hydroxyl radical (
. OH) are now recognized as signaling molecules in response to stimuli. In order to clarify which compound(s) is involved in etoposide-induced ceramide formation, the eects of speci®c antioxidants such as superoxide dismutase (SOD) for O 2 7.
, catalase for H 2 O 2 , and sodium formate for . OH were ®rst examined. Sodium formate failed to protect cells from apoptosis, indicating that . OH may not be involved in p53-dependent apoptosis by etoposide (Figure 2a ). Catalase resulted in a partial inhibition of etoposide-induced apoptosis in a concentration-dependent manner. However, even in the presence of excess amounts of catalase (10 000 U/ ml), nearly half of cells underwent apoptotic death (Figure 2b ). In contrast, SOD showed a signi®cant protective eect against etoposide-induced apoptosis in a concentration-dependent manner ( Figure 2c ). These results suggest that O 2 7. plays an important role and that conversion of O 2 7. to its downstream compound, H 2 O 2 may not be required to mediate the apoptotic process.
We next measured intracellular ROS production with the ROS-sensitive¯uorescent dyes hydroethidium (HE) and 2', 7'-dichloro¯uorescin diacetate (DCFH-DA). O 2 7. is able to oxidize HE to the¯uorescent ethidium and H 2 O 2 is able to oxidize DCFH to 2',7'-dichloro¯uorescein (DCF) (Rothe and Valet, 1990; Narayanan et al., 1997; Li et al., 1999) . In U87-LXSN cells, etoposide gave rise to a sharp and transient increase in the intracellular ethidium¯uorescence peaking at 6 h (threefold increase over the control level), which was followed by a gradual decrease ( Figure 3a ). Etoposide also gave rise to the increase in DCF¯uorescence, which began to increase at 3 h after the exposure of etoposide in U87-LXSN cells. The maximal level was obtained at 12 h (2.5-fold increase over the control level) and sustained to 24 h ( Figure 3b ). In contrast, signi®cant increases in neither ethidium nor DCF¯uorescence were observed in U87-W E6 and U-373 MG cells during the time course examined (Figure 3a ,b). Both 1000 U/ml SOD and 10 000 U/ml catalase had no eects on p53 expression induced by etoposide (Figure 4 ). These results place p53 upstream of ROS generation in the pathways leading to cell death.
Induction of apoptosis by O 2
7.
-releasing agent, pyrogallol
To further evaluate the pro-apoptotic potential of O 2 7.
, U-87 MG cells were stimulated by O 2 7.
-releasing agent, pyrogallol (Xie et al., 1998; Moreno-Manzano et al., 2000) . Hoechst 33258 staining showed that pyrogallol induced condensation and fragmentation of nuclei, typical feature of apoptosis (Figure 5a ). The percentage of apoptotic cells increased from 1.6+0.3% (untreated control) to 52.3+2.5% by the treatment with 1 mM pyrogallol (Figure 5b ). In addition, pyrogallol gave rise to an increase in intracellular ceramide content for 24 h scavenger, Tiron (5 mM) as well as SOD (1000 U/ml) signi®cantly reduced apoptosis induced by pyrogallol (Figure 5b ). Ceramide accumulation caused by pyrogallol was also inhibited by SOD or Tiron (Figure 5c ). However, catalase, even at 10 000 U/ml, showed only a modest inhibitory eect on pyrogallol-induced apoptosis and ceramide formation. These results also indicate the primary role of O 2 7.
, but not H 2 O 2 , in induction of SM hydrolysis by N-SMase. The eects of ceramide on p53 expression and formation of ROS were further examined. As shown in Table 2 , treatment of cells expressing dierent p53 status for 24 h with 300 milliunits/ml of Staphylococcus aureus or Bacillus cereus SMases, which are known to induce a signi®cant elevation of intracellular ceramide (Zhang et al., 1997) , caused equivalent apoptotic cell death regardless of p53 expression status. Apoptosis induced by a cell-permeable C 2 -ceramide was also independent of p53 status (Table 3) . However, these treatments failed to induce signi®cant changes in GSH levels. Pretreatment of cells with 1000 U/ml SOD or 10 000 U/ml catalase could not protect cells from death caused by C 2 -ceramide (Table 3) . These results indicate inability of ceramide to induce ROS production. Furthermore, bacterial SMases or C 2 -ceramide treatment did not induce p53 expression (Figure 6a,b) . Taken together, neither exogenous SMaseinduced nor C 2 -ceramide-induced apoptosis was dependent on the expression of p53 and on ROS production.
Induction of functional p53 in MTp53ts-transfected U-373 MG cells
To further con®rm the ordering of p53-dependent apoptotic events, U-373 MG and T-98 G cells expressing mutant p53 were transfected with an -releasing agent, for 24 h in the presence or absence of 1000 U/ml SOD, 5 mM Tiron, and 10 000 U/ml catalase. expression plasmid encoding the temperature-sensitive p53 val 138 mutant (MTp53ts) that assumes mutant conformation at 37.58C and wild-type conformation at 32.58C (Michalovitz et al., 1990; Lang et al., 1998) . In U-373 MG cells, this MTp53ts caused DNA fragmentation (Figure 7a) , and classical apoptotic morphological features such as cellular shrinkage and detachment from surrounding cells at 48 h postinduction ( Figure 7c ). The nuclear staining with Hoechst 33258 revealed the condensation and fragmentation of nuclei at 48 h (Figure 7e ). Strong ethidium¯uorescence was observed at 24 h in cells prelabeled with HE (Figure 7g ). In contrast, cells transfected with control vector showed no signs of apoptosis (Figure 7b,d ) and generation of O 2 7. (Figure  7f ). Similar ®ndings were also observed in T-98 G cells transfected with MTp53ts (data not shown).
Generations of O 2
7. and ceramide are proportional to p53 expression levels
We obtained at least three U-373 MG clones expressing dierent levels of p53 at 48 h post-induction following MTp53ts transfection (Figure 8 ). The function of the induced p53 protein was con®rmed by the expression of p21
, a product of p53 responsive genes (El-Deiry et al., 1993) . Moreover, increases in ethidium¯uorescence and ceramide accumulation were observed in proportional to the levels of p53 expression and the rate of apoptosis in MTp53 transfectants (Figure 8 ).
Effects of antioxidants on apoptosis induced by MTp53ts
In order to further clarify the involvement of and precise roles for individual ROS, namely O 2 7.
, H 2 O 2 , and . OH, in p53-induced apoptosis in MTp53H cells, the inhibitory eects of antioxidants were examined. In agreement with etoposide-induced apoptosis, p53-induced apoptosis was signi®cantly inhibited by 1000 U/ml SOD, and was partially prevented by 10 000 U/ml catalase (Figure 9 ). However, 100 mM sodium formate failed to protect MTp53H cells from p53-induced apoptosis (Figure 9 ).
Ordering of p53-induced apoptotic events
In HE-prelabeled MTp53H cells, time-dependent increase in ethidium¯uorescence was observed after induction by temperature-shift (Figure 10 ), indicating the production of O 2 7.
. Finally, the time-dependent changes in intracellular O 2
7.
generation, N-SMase activity, ceramide, and the number of apoptotic cells in MTp53H cells are summarized in Figure 10 . These data suggest a cascade in which functional p53 induces the production of intracellular O 2 7.
, but not its downstream compounds H 2 O 2 and
. OH, and in turn leads to the activation of N-SMase and accumulation of intracellular ceramide, thereby resulting in apoptotic cell death.
Discussion
Ceramide has been proposed as a mediator of apoptosis (Hannun, 1996) , senescence (Venable et al., 1995) , and Rb dephosphorylation with resultant cell cycle arrest at the G 0 /G 1 phase (Jayadev et al., 1995) . p53 accumulation can drive the cells towards apoptosis in response to genotoxic damages induced by girradiation, ultraviolet light, and the chemotherapeutic U87-LXSN, U87-W E6, U-373 MG, and T-98 G cells were treated with 50 mM C 2 -ceramide in the presence or absence of 1000 U/ml SOD or 10 000 U/ml catalase for 24 h Figure 6 Failure to induce p53 by bacterial SMase or C 2 -ceramide. U87-LXSN or U87-W E6 cells were treated with 300 milliunits/ml of bacterial SMase from S aureus (a) or 50 mM C 2 -ceramide (C 2 -cer) (b) for 24 h. p53 protein levels were analysed by immunoblotting. Results are representative of three separate experiments with compatible outcomes Oncogene p53 regulates ceramide response through ROS M Sawada et al agents (Kuerbitz et al., 1992; Hartwell and Kastan, 1994) , which are known to stimulate accumulation of ceramide. p53 also plays an important role in the regulation of cell cycle in the G 0 /G 1 phase (Kuerbitz et al., 1992) . These striking similarities in biological functions between ceramide and p53 tempted us to elucidate their mutual relationship. The results obtained in the present study indicate that upregulation of functional p53 induced either by etoposide or by transfection of an inducible MTp53ts caused ceramide generation through N-SMase activation, leading to apoptotic death of gliomas. p53 is not a downstream mediator of ceramide, since it was not upregulated and was not required during apoptosis induced by exogenous C 2 -ceramide or bacterial SMases. Therefore, in p53-dependent apoptotic pathway of gliomas, an increase in p53 levels leads to accumulation of endogenous ceramide, as previously observed in Molt-4 and L292 cells (Dbaibo et al., 1998) . Several lines of evidence indicate that ceramide is mainly produced from SM by the action of N-SMase and/or A-SMase during apoptosis. N-SMase has been implicated in apoptosis caused by serum starvation, tumor necrosis factor (TNF)-a, and some chemotherapeutic agents (Jayadev et al., 1995; Liu et al., 1998) . In contrast, A-SMase has been suggested to be activated in cells exposed to radiation (HaimovitzFriedman et al., 1994) , Fas (Cifone et al., 1994) , and TNF-a (Schwandner et al., 1998) . These two types of SMases dier in subcellular location, pH optimum, and role in cell regulation. In etoposide-treated glioma cells expressing functional p53, the activity of N-SMase, but not A-SMase, was increased, as observed previously (Sawada et al., 2000a,b) . Moreover, induced expression of functional p53 by MTp53ts gave rise to activation of N-SMase. The downstream eectors of p53 remain poorly understood, but some recent evidence suggests a role for ROS as a potential mediator of p53-dependent apoptosis (Johnson et al., 1996; Polyak et al., 1997; Li et al., 1999) . In the present study, etoposide-induced ROS generation well correlated with expression of p53 and the onset of apoptosis. Furthermore, overexpression of functional p53 by MTp53ts was sucient to induce apoptosis in human glioma cells expressing mutant p53, as previously reported (Gomez-Manzano et al., 1996) . During the early time-points in MTp53 transfectants, cells showed no evidence of ceramide accumulation and morphological changes, indicating that p53-induced ROS production may constitute a signal for ceramide-mediated apoptosis, but not a consequence of the cellular changes associated with apoptosis. The results obtained from MTp53ts clones expressing three dierent levels of p53 revealed that the extent of ROS production is proportional to the amount of functional p53 protein.
ROS, including O 2
7.
, H 2 O 2 , and . OH, are now recognized as signaling molecules that are mobilized in response to stimuli. All of these ROS have the potential for triggering apoptosis (Buttke and Sandstrom, 1994; Jacobson, 1996; Moreno-Manzano et al., 2000) . However, the involvement of and precise roles for individual ROS in p53-dependent apoptotic process are not well understood. Therefore, in the present study, we have ®rst examined the involvement of O 2 7. , H 2 O 2 , and
. OH in p53-dependent apoptosis by etoposide using three antioxidants such as SOD, catalase, and sodium formate. Sodium formate, even at 100 mM, did not have any signi®cant inhibitory eects, indicating that the generation of . OH may play a minimal role in the induction of p53-mediated apoptosis by etoposide. Of the antioxidants tested, the ability of SOD to protect cells supports the selective and crucial roles for O 2 7. in etoposide-induced apoptosis. Since SOD scavenges O 2 7. by catalyzing the conversion of O 2 7. to H 2 O 2 , the inhibitory eect of SOD also excludes the involvement of H 2 O 2 in mediating apoptosis by etoposide. Catalase showed a partial inhibition of etoposide-induced apoptosis in a concentration-dependent manner. One interpretation of its partial protective eect is that hydrolysis of H 2 O 2 by catalase accelerates conversion of O 2 7. to H 2 O 2 , resulting in the reduction of O 2 7. level. This possibility was con®rmed by the use of pyrogallol in the presence Figure 9 Eects of antioxidants on apoptosis induced by MTp53ts. Eects of the three antioxidants, 1000 U/ml SOD, 10 000 U/ml catalase or 100 mM sodium formate on apoptosis induced by MTp53ts in MTp53H cells. Data are means+s.d. from three independent experiments, each performed in duplicate. *P50.05 and **P50.01 versus MTp53H alone -sensitive¯uorophore HE. NSMase activity (~) was measured by a mixed micelle assay system with [methyl-14 C]SM at pH 7.5. Ceramide content (~) was determined by the E. coli diacylglycerol kinase assay. Apoptotic cell death (&) was assessed by staining with Hoechst 33258. As for O 2 7. production, the responses at 0 and 24 h were designed as 0% and 100%, respectively. As for the other events, 0 and 48 h were done as 0 and 100%, respectively. Data are means+s. , may be subsequently produced during the apoptotic process. In agreement with etoposide-induced apoptosis, the involvement of O 2 7. in p53-induced apoptosis by MTp53ts was also con®rmed by experiments using antioxidants and by measurement of it with¯uorescent dye, HE.
We here demonstrate that p53 may play a role in the regulation of ROS production in p53-dependent apoptotic pathway of human glioma cells. Data from several experimental systems are consistent with our model. For example, apoptosis induced by irradiation, which is dependent on p53 in certain cell types, has been proposed to operate through a process involving ROS (Borek, 1987) . In addition, an SV40 large-Tantigen mutant, which binds p53 only at the permissive temperature, induces apoptosis of rodent embryo cells at the non-permissive temperature through a ROSrelated mechanism (Vayssiere et al., 1994) . Apoptosis induced by overexpression of p53 using adenovirus vector in human smooth muscle cells is ROS-dependent (Johnson et al., 1996) . However, there are several exceptions. Rat smooth muscle cells were resistant to the induction of apoptosis by p53 overexpression (Johnson et al., 1996) . NAC, a non-selective antioxidant, failed to prevent p53-induced apoptotic cell death in human osteosarcoma Saos-2 cells (Schuler et al., 2000) . Therefore, the events that p53 induces ROS formation are likely to be species-or cell type-speci®c. Furthermore, it is unknown why some cells enter into apoptosis following p53 expression, while others undergo a prolonged growth arrest (Polyak et al., 1996) . This query may be explained by the possibility that dierent cells have dierent capacities to overcome oxidative stress. This possibility may be supported by the fact that the response to ROS varies signi®cantly with cell types and growth conditions (Kroemer et al., 1997) .
In summary, we would like to propose a hypothetical death signaling sequence for ceramide generation in glioma cells induced by chemotherapeutic agents; p53-dependent production of O 2 7. induced by etoposide may trigger N-SMase activation and then causes ceramide accumulation. This knowledge provides the ®rst potential cascade to resolve how DNA damaging agents trigger ceramide generation. Further investigations regarding the ceramide pathway, especially the mechanism of p53-dependent O 2 7. formation and the identi®cation of downstream component(s) of ceramide, will lead to better understanding of the molecular mechanism of apoptosis induced by chemotherapeutic agents, and will give us a novel approach for the treatment of malignant gliomas, which are often resistant to chemotherapeutic treatments.
Materials and methods
Materials
HE, DCFH-DA, GSH, bacterial (Staphylococcus aureus and Bacillus cereus) SMases, SOD, catalase, sodium formate, and the cell-permeable O 2 7. scavenger, Tiron were obtained from Sigma (St. Louis, MO, USA). Trans-It was purchased from Takara (Tokyo, Japan). Anti-rat p21 monoclonal antibody was from Santa Cruz Biotech. (Santa Cruz, CA, USA). Antimouse p53 (Ab-6) monoclonal antibody was from Calbiochem-Novabiochem (Cambridge, MA, USA). Other reagents were obtained from previously noted sources (Sawada et al., 2000a,b) .
Cells and transfections
The human U-87 MG, U-373 MG, and T-98 G glioblastoma cell lines were obtained from American Type Culture Collection (Rockville, MD, USA). The cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 100 units/ ml penicillin and 100 mg/ml streptomycin (FBS/DMEM) in a humidi®ed atmosphere containing 5% CO 2 at 378C. Prior to treatment with etoposide or C 2 -ceramide, the cells were plated at a density of 5610 4 ml and cultured for 2 days. For treatment with C 2 -ceramide, cells were cultured in DMEM without FBS for the last 24 h. Then, 50 mM C 2 -ceramide was delivered into the culture medium without FBS (Sawada et al., 2000b) .
The retrovirus vector pLXSN ± 16E6SD was constructed by inserting 16E6SD BamHI fragment from pLRHL ± 16E6SD (Kiyono et al., 1997) into the BamHI site of pLXSN. pLXSN ± 16E6SD ± 8S9A10T was constructed by inserting an EcoRI ± SspI fragment from pLXSN ± 16E6 ± 8S9A10T (Klingelhutz et al., 1996) and an SspI ± BamHI fragment from between EcoRI and BamHI sites of pLXSN. Preparation of E6-and LXSN-retroviruses, and infection protocols have been described (Halbert et al., 1991) except that an amphotrophic packaging cell line FLYA13 (Cosset et al., 1995) was used instead of PG13. U87 ± LXSN, U87-W E6, and U87-M E6 cell lines were obtained by infecting U87 MG cells with LXSN, LXSN ± 16E6SD, and LXSN ± 16E6SD ± 8S9A10T retroviruses, respectively, followed by drug selection with 800 mg/ml G418 for 2 weeks. The mutant E6 (16E6SD-8S9A10T) is inactive for degrading p53 but active for other known E6 functions (Kiyono et al., 1998) .
The p53ts val 138 encodes a mutant protein with a substitution from wild-type alanine to valine at position 138. The wild-type human p53 cDNA cloned into pCMV was kindly provided by Dr T Takahashi (Aichi Cancer Center, Japan). The p53ts val 138 was constructed from the wild-type p53 by site-directed mutagenesis, employing the gapped duplex method (Kramer et al., 1984) . U-373 MG and T-98 G cells were stably transfected with p53ts val 138 in pCMV using Trans-It. After selection with 800 mg/ml G418 for 2 weeks, resistant cells were cloned by limiting dilution.
Fluorescent microscopy
Apoptotic cells stained with Hoechst 33258 were quanti®ed by¯uorescent microscopic analysis (Yoshimura et al., 1998) . Brie¯y, cells were ®xed in 1% glutaraldehyde for 30 min. The cells were then stained with 10 mM Hoechst 33258 for 10 min. Nuclear morphology was observed under a¯uorescent microscope (Olympus BX60, Tokyo, Japan).
Measurement of intracellular GSH level
Intracellular GSH content was determined according to the previously described method (Yoshimura et al., 1999) . In brief, the harvested cells were suspended in 150 ml of water and 5-sulfosalicylic acid was added to a ®nal concentration of 2%. The precipitated proteins were pelleted by centrifugation at 2000 g for 10 min at 48C. Aliquots of the soluble supernatant were mixed with 125 mM sodium phosphate buer (pH 7.5) containing 6.3 mM EDTA, 0.21 mM NADPH, and 0.6 mM 5, 5-dithiobis (2-nitrobenzoic acid) in a total volume of 1 ml. On addition of glutathione reductase, the increase in absorption at 412 nm was monitored to determine the amount of GSH in the sample. A reference curve was generated with known amounts of GSH standards.
Detection of intracellular ROS
Intracellular production of ROS was measured by using HE and DCFH-DA. HE and DCFH-DA have been shown to be relatively speci®c for O 2 7. and H 2 O 2 , respectively (Rothe and Valet, 1990; Narayanan et al., 1997; Li et al., 1999) . O 2 7. is able to oxidize HE to yield ethidium and H 2 O 2 is able to oxidize DCFH to the¯uorescent DCF. HE dissolved in DMSO or DCFH-DA dissolved in ethanol was added to the washed cells and incubated for 5 min at 378C. The ®nal concentrations of HE and DCFH-DA were 2 and 5 mM, respectively. After the cells were stained, they were collected in a microcentrifuge. Ethidium or DCF¯uorescence was measured using a spectro¯uorometer (Hitachi F-3000, Japan). In some cases, intracellular ethidium¯uorescence was visualized with a Leica Laser confocal scanning microscope (Heidelberg, Germany).
SMase assay
Membrane fraction was prepared as described previously (Sawada et al., 2000a,b) . The activities of both neutral and acid SMases were determined using a mixed micelle assay system . For measuring N-SMase activity, the membrane fractions (20 mg protein) were mixed with [methyl- 
Western blot analysis
Cells were solubilized with ice-cold lysis buer containing 1% Triton X-100, 50 mM NaCl, 25 mM HEPES (pH 7.4), 1 mM EDTA, 1 mM EGTA, 1 mM phenylmetylsulfonyl¯uoride, and 10 mg/ml E-64. Extracted proteins (60 mg/well) were separated by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS ± PAGE) on 10 or 13% polyacrylamide gels, and were electrophoretically transferred onto Immobilon-P membrane. Blocking was performed in Tris-buered saline containing 5% skimmed-milk powder and 0.1% Tween-20. The membranes were probed with antibodies against p53, p21 or actin. Detection was performed with ECL system. Protein content was determined with BCA protein assay using bovine serum albumin as a standard.
Statistical analysis
Data are expressed as means+s.d. Signi®cance was assessed by two-way ANOVA, followed by Schee's post hoc test. P values less than 0.01 was considered as signi®cant.
Abbreviations A-SMase, acid sphingomyelinase; DCF, 2',7'-dichloro¯uor-escein; DCFH-DA, 2',7'-dichloro¯uorescin diacetate; DMEM, Dulbecco's modi®ed Eagle's medium; FBS, fetal bovine serum; GSH, reduced glutathione; H 2 O 2 , hydrogen peroxide; HE, hydroethidium; HPTLC, high performance thin-layer chromatography; HPV, human papillomavirus; MTp53ts, temperature-sensitive human p53 val 138 mutant; NAC, N-acetylcysteine; N-SMase, neutral and magnesiumdependent sphingomyelinase; O 2 7. , superoxide anion; . OH, hydroxyl radical; PDTC, pyrrolidinedithiocarbamate; ROS, reactive oxygen species; SDS ± PAGE, sodium dodecylsulfate polyacrylamide gel electrophoresis; SM, sphingomyelin; SOD, superoxide dismutase; TNF, tumor necrosis factor.
